Tooth extractions in patients under antiresorptive therapy for osteoporosis: Primary closure of the extraction socket with a mucoperiosteal flap versus application of platelet-rich fibrin for the prevention of antiresorptive agent-related osteonecrosis of the jaw

被引:18
|
作者
Poxleitner, Philipp [1 ,2 ]
Steybe, David [1 ]
Kroneberg, Philipp [1 ]
Ermer, Michael Andreas [1 ]
Yalcin-Ulker, Gul Merve [3 ]
Schmelzeisen, Rainer [1 ]
Voss, Pit Jacob [1 ]
机构
[1] Univ Freiburg, Med Ctr, Fac Med, Dept Oral & Maxillofacial Surg, Freiburg, Germany
[2] Univ Freiburg, Fac Med, Berta Ottenstein Programme Clinician Scientists, Freiburg, Germany
[3] Istanbul Okan Univ, Dept Oral & Maxillofacial Surg, Fac Dent, Istanbul, Turkey
关键词
Osteonecrosis of the jaw; Antiresorptive agent; Prevention; Autologous platelet concentrate; Platelet-rich fibrin; BISPHOSPHONATE-RELATED OSTEONECROSIS; MEDICATION-RELATED OSTEONECROSIS; PRIMARY WOUND CLOSURE; DENTAL EXTRACTIONS; BONE; RISK; PRF; COMPLICATIONS; ASSOCIATION; CONCENTRATE;
D O I
10.1016/j.jcms.2020.02.006
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: The aim of this study was to compare primary closure of the extraction socket to application of platelet-rich fibrin (PRF) without subsequent primary closure for the prevention of osteonecrosis of the jaw (ONJ) in patients administered antiresorptive therapy for osteoporosis. Materials and methods: Primary closure of the extraction socket was performed with a mucoperiosteal flap and two-layer suturing or PRF was inserted into the extraction socket without subsequent primary closure. In all patients, intra- and postoperative complications as well as the overall treatment outcome were recorded. Results: The patient sample consisted of 77 patients; primary closure with a mucoperiosteal flap was performed in 39 patients (group A), and application of PRF without subsequent primary closure was performed in 38 patients (group B). There were no statistically significant differences (p > 0.05) between the two groups in terms of age and gender, duration and type of antiresorptive therapy, teeth to be extracted (number, location and type) as well as comorbidities. No intraoperative complications occurred in either of the groups. Postoperative complications were found in 6 patients in group A and in one patient in group B. Analyzing risk factors for these complications, the highest OR (6.72 with p = 0.085 in univariate analysis; 12.81 with p = 0.052 in multivariate analysis) was found for the type of procedure (group A/group B). All patients had complete mucosal coverage without any signs of antiresorptive agent-related osteonecrosis of the jaw at the final control examination 90 days postoperatively. Conclusion: Based on the results of this study, the use of PRF can be recommended as a preventive measure in patients requiring tooth extractions while being under antiresorptive therapy for osteoporosis. (C) 2020 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:444 / 451
页数:8
相关论文
共 5 条
  • [1] Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease
    Yuichiro Fujieda
    Mototsugu Doi
    Takuya Asaka
    Masahiro Ota
    Ryo Hisada
    Naoki Ohnishi
    Michihiro Kono
    Hiraku Kameda
    Daigo Nakazawa
    Masaru Kato
    Olga Amengual
    Masahiko Takahata
    Shinsuke Yasuda
    Yoshimasa Kitagawa
    Tatsuya Atsumi
    Journal of Bone and Mineral Metabolism, 2020, 38 : 581 - 588
  • [2] Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease
    Fujieda, Yuichiro
    Doi, Mototsugu
    Asaka, Takuya
    Ota, Masahiro
    Hisada, Ryo
    Ohnishi, Naoki
    Kono, Michihiro
    Kameda, Hiraku
    Nakazawa, Daigo
    Kato, Masaru
    Amengual, Olga
    Takahata, Masahiko
    Yasuda, Shinsuke
    Kitagawa, Yoshimasa
    Atsumi, Tatsuya
    JOURNAL OF BONE AND MINERAL METABOLISM, 2020, 38 (04) : 581 - 588
  • [3] The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: an observational study
    Besi, Eleni
    Pitros, Panagiotis
    ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG, 2024, 28 (02): : 785 - 793
  • [4] Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab
    Akihiko Matsumoto
    Masanori Sasaki
    Rainer Schmelzeisen
    Yukiko Oyama
    Yoshihide Mori
    Pit Jacob Voss
    Clinical Oral Investigations, 2017, 21 : 127 - 134
  • [5] Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab
    Matsumoto, Akihiko
    Sasaki, Masanori
    Schmelzeisen, Rainer
    Oyama, Yukiko
    Mori, Yoshihide
    Voss, Pit Jacob
    CLINICAL ORAL INVESTIGATIONS, 2017, 21 (01) : 127 - 134